The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal

Endocrine

Volumn 30, Issue 3, 2006, Pages 377-381

  Tanrikulu, Sevda ^a   Erbil, Yeşim ^a   Ademoglu, Evin ^a   Işsever, Halim ^a   Barbaros, Umut ^a   Kutlutürk, Faruk ^a   Özarmaǧan, Selçuk ^a   Tezelman, Serdar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

CTLA 4; Graves' disease; Polymorphisms; Tg E33SNP

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; THYROGLOBULIN;

ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34347340624     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-006-0017-0     Document Type: Article

References (19)

1. Prabhakar, B. S., Rebecca, S. B., and Smith, T.J. (2003). Endocr. Rev. 24, 802-835.
2. Riley, J. L. and June, C. H. (2005). Blood 105, 13-21.
3. Gribben, J. G., Freeman, G. J., Boussiotis, V. A., et al. (1995). Proc. Natl. Acad. Sci. USA 92, 811-815.
4. Ikegami, H., Awata, T., Kawasaki, E., et al. (2006). J. Clin. Endocrinol. Metab. 91, 1087-1092.
5. Sahin, M., Erdogan, M. F., and Erdogan, G. (2005). Eur. J. Int. Med. 16, 352-355.
6. Chistiakov, D. A. and Turakulov, R. I. (2003). J. Mol. Endocrinol. 31, 21-36.
7. Heward, J. M., Allahabadia, A., Armitage, M., et al. (1999). J. Clin. Endocrinol. Metab. 84, 2398-2401.
8. Kristiansen, O. P., Larsen, Z. M., and Pociot, F. (2000). Genes Immun. 1, 170-184.
9. Walsh, E. C., Guschwan-McMahon, S., Daly, M. J., Hafler, D. A., and Rioux, J. D. (2004). J. Autoimmun. 21, 111-116.
10. Vaidya, B. and Pearce, S. (2004). Eur. J. Endocrinol. 150, 619-626.
11. Park, Y. J., Chung, H. K., Park, D. J., et al. Thyroid 10, 453-459.
12. Kouki, T., Sawai, Y., Gadrine, C. A., Fisfalen, M. E., Alegre, M. L., and DeGroot L. J. (2000). J. Immunol. 165, 6606-6611.
13. Yaganawa, T., Taniyama, M., Enomoto, S., et al. Thyroid 7, 843-846.
14. Awata, T., Kurihara, S., Iitaka, M., et al. Diabetes 47, 128-129.
15. Hadj Kacem, H., Bellassoued, M., Bougacha-Elleuch, N., Abid, M., and Ayadi, H. (2001). Clin. Immunol. 101, 361-365.
16. Donner, H., Rau, H., Walfish, P. G., et al. (1997). J. Clin. Endocrinol. Metab. 82, 143-146.
17. Collins, J. E., Heward, J. M., Howson, J. M. M., et al. J. Clin. Endocrinol. Metab. 89, 6336-6339.
18. Gough, S. (2004). Trends Mol. Med. 10, 302-305.
19. Ban, Y., Greenberg, D. A., Conception, E., Skrabanek, L., Villanueva, R., and Tomer, Y. (2003). Proc. Natl. Acad. Sci. USA 100, 11519-15124.